Continuing Pharmacy Education / CE Master List / Long Acting Injectables LIVE Workshop-January 16, 2025
Please use this button to register in our system as a new user, or to purchase a CE Activity.
For free CE's, returning users can simply click the "TAKE TEST/EVALUATION" button on the right.
Please use this button when you have completed the CE Activity and are ready to take the quiz and complete the evaluation.

Long Acting Injectables LIVE Workshop-January 16, 2025

About this Course

Pharmacists possess the training and skills necessary to administer certain long-acting injectable (LAI) medications used in the management of mental illnesses and substance use disorders. Through collaborative practice agreements, pharmacists can administer Long Acting Injectables in almost every state. In some states, including the state of Connecticut, this occurs via collaborative agreements, and necessary injection and disease state training.  Administration of these medications by pharmacists can increase accessibility of care for patients.

UConn has developed web-based and LIVE continuing pharmacy education activities to enhance pharmacists’ skills and help them make sound clinical decisions about long acting injectables administration. This course includes eight hours of CPE (or eight hours of credit), required by the State of Connecticut.  Successful completion of these eight hours (with four activities consisting of three hours online pre-requisite work and five hours of LIVE CE) will earn the pharmacist a Certificate in Long-Acting Injectables of Psychotropic Medication.

The LIVE Workshop listed below is required to earn the Long-Acting Injectable Psychotropic Medication Pharmacist certificate. The Long-Acting Injectable Psychotropic Medication Pharmacist Certificate Training Program costs $299 and includes both the 3 online prerequisites and this full day of LIVE training.

Thursday, January 16, 2025
8:30 am - 3:15 pm
Pharmacy Biology Bldg-Room 229
Storrs, CT

A light breakfast and lunch will be served.

Target Audience

Pharmacists who are interested in administering long acting injectable psychotropic medications to their patients.

This activity is NOT accredited for technicians.

Pharmacist Learning Objectives

At the end of this application and practice-based continuing education activity, the learner will be able to:

Describe the impact of stigma within the healthcare system and utilize non-stigmatizing terminology when talking to and about patients with psychiatric and/or substance use disorders
Identify patient barriers to obtaining appropriate treatment for psychiatric and/or substance use disorders
Explain the potential impact of LAI medications on patient health outcomes
Identify the key components of the Collaborative Practice Agreement associated with LAI medications.
Describe the key components of the Notes on Injection Clinical Encounter (NICE) documentation form.
Apply different best practices for documentation, maintenance of files, and communications with

prescribers.

 
Describe the steps in the safe and effective use of different LAI medications for schizophrenia, bipolar

disorder,and substance use disorder.
Compare and contrast how the administration techniques are similar or different for the different LAI

medications.
Demonstrate the use sterile injection techniques and best practices in the administration of different LAI

Release Date

Released:  1/31/2024
Expires:  1/31/2027

Course Fee

$299

ACPE UAN

0009-0000-24-008-H01-P

Accreditation Hours

5.0 hours of CE

Bundle Options

If desired, pharmacists can register for the entire Long-Acting Injectable Psychotropic Medication Pharmacist Certificate Training Program
or for the individual online activities.   The Certificate consists of three activities in our online selection, and a 5 hour LIVE activity.

You may register for individual online topics at $17/CE Credit Hour, or for the Entire LAIA Certificate at $299.00 which includes 5 hours of LIVE CE and the 3 online pre-requisites listed below.

You must register for ALL 4 activities to receive the bundled pricing of $299.00

Accreditation Statement

ACPE logo

The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit will be issued for 5.0 hours (or 0.5 CEUS) for activity ACPE UAN 0009-0000-24-008-L01-P. UConn will be award credits once learner attends the full 5 hours, successfully passes the injection assessment and submits their evaluation.  Your CE credits will be uploaded to your CPE monitor profile within 24 hours of your submitting the evaluation.

Grant Funding

There is no grant funding for this activity.

Requirements for Successful Completion

To receive CE credit for this activity, the leaner must attend the full 5 hours, pass the injection assessment, and submit their evaluation online.

To Receive the Certificate in Long Acting Injectables the learner must complete this live workshop, and the 3 online pre-requisites.

Faculty

Kristin Waters, PharmD, BCPS, BCPP,
Assistant Clinical Professor
UConn School of Pharmacy
Storrs, CT

Nathaniel Rickles, PharmD, PhD, BCPP, FAPhA
Professor of Pharmacy Practice
UConn School of Pharmacy
Storrs, CT

Sindu Sahadevan, PharmD, BCGP
Medical Science Liaison-CNS Psychiatry
Teva Pharmaceuticals
New York, NY

Sharon Spicer, BSRN
Director of Quality Assurance and Customer Success
Connecticut Pharmacy & Long Term Care
Wallingford, CT

Jehan Marino, PharmD, BCPP
Medical Science Liaison Director-Neuroscience Field Medical Affairs
Otsuka Pharmaceutical Development & Commercialization, Inc.
New York, NY

Yasmin Togun, PhD, MPH
Medical Science Liaison
Otsuka Pharmaceutical Development & Commercialization, Inc.
New York, NY

 

 

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Dr. Waters is a consultant with Janssen Pharmaceuticals. She will discuss all drugs without bias. All financial interests with ineligible companies (as noted) have been mitigated.

Dr. Sahadevan is a medical Science liaison with Teva Pharmaceuticals

Drs. Marino and Togen are medical science liaisons with Otsuka Pharmaceuticals

Dr. Rickles and Sharon Spicer have no relationships with ineligible companies.

Disclaimer

This activity may contain discussion of off label/unapproved use of drugs. The content and views presented in this educational program are those of the faculty and do not necessarily represent those of the University of Connecticut School of Pharmacy. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.